信息搜索
信息关键字:药
 

共有4382条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220]

·中药行业:给予“看好”评级2011-6-3 16:40:42
·海正药业:携手辉瑞 国际合作深化2011-6-3 16:32:07
·联环药业600513 - 主力持仓成本 2011-6-3 15:42:14
·兴业证券:医药板块正进入投资区间2011-6-3 10:29:19
·医药股估值接近历史底部2011-6-3 10:24:44
·资金流向:两市5亿资金净流入 主力加仓医药股2011-6-3 10:04:09
·发改委调控中药价102种中成药或调价2011-6-3 9:59:42
·医药股估值近历史底部 5股抢仓2011-6-3 9:01:18
·科伦药业的双驾马车(组图)2011-6-3 7:34:03
·海正药业拟与辉瑞公司合作药物项目 金额近3亿美元2011-6-2 19:40:16
·渤海证券:医药板块估值已经处于合理水平2011-6-2 19:06:42
·A股6月开门红私募看好低估值银行医药2011-6-2 16:07:29
·7成中药材再涨价发改委拟降102种中成药价格2011-6-2 11:40:04
·恒瑞医药:艾瑞昔布获批 创新药物研究进入收获期2011-6-2 10:54:16
·瑞康医药:“广覆盖、深挖掘”的医药商业开拓者2011-6-2 10:45:54
·A股6月开门红私募看好低估值银行医药2011-6-2 9:43:37
·400亿巨资研发新特药 13股直追莱茵生物2011-6-2 8:05:28
·医药:成本压力加大中药机会显现 荐7股2011-6-2 7:47:36
·干旱为中药材涨价添一把火2011-6-2 7:43:41
·恒瑞医药:艾瑞昔布获批 创新药物研究进入收获期2011-6-1 18:17:52

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220]